Product News
Linneo Health Awarded EU GMP License
The certification further expands the company's abilities to manufacture finished dosage forms alongside dried flowers and APIs.
KRTL Allies With Entexs to Expand THC Extraction Technology
At full capacity, KRTL expects to be able to produce over 8,500 liters of mid-potency full spectrum or high-potency broad spectrum THC distillate per year per extraction unit.
Broughton Launches New Cannabinoids Service for Medicinal Cannabis & CBD Manufacturers
New services focus on providing support with the toxicology and stability data that manufacturers must submit to regulators when seeking product approvals.
Rapid Test for Emerging Viral Pathogen in Cannabis Now Available
Agdia is happy to announce the commercialization of a rapid, user-friendly, RNA-based assay, on their AmplifyRP® XRT platform, for the detection of Lettuce chlorosis virus.
Zen Medicine Increase Cannabinoids by 10% with Kind LED Cannabis Grow Light
Zen Medicine's cofounder also praises the Kind LED X2 grow light for cutting commercial growing expenses despite a recent expansion.
Fluence & REMY Partner on LED Lighting Tech in Israel
REMY’s expertise, paired with Fluence’s products and evidence-based best practices for optimal lighting strategies at each phase of cannabis growth, has placed the companies’ collaborative designs in the three core categories of medical cannabis facilities in Israel: greenhouse, indoor and vertical farms.
Pressure BioSciences Doubles Growth Projections For Nano-emulsion Contracts
Pressure BioSciences has announced that its participation at the recent San Francisco and Chicago Cannabis Drinks Expos produced over 60 strong leads for prospective contracts serving the cannabis beverages sector.
Cannabis Consumers in California Are Being Defrauded and It’s the Regulator's Fault, Says Infinite Chemical Analysis Labs
The THC content you see on a label when you walk into a dispensary? There is a very good chance the number is false, writes Infinite Chemical Analysis Labs.
InMed Pharma Launches Sales of THCV
InMed Pharmaceuticals Inc., a manufacturer of rare cannabinoids, has announced it has launched B2B sales of the rare cannabinoid delta 9-dominant tetrahydrocannabivarin (“d9-THCV”) into the health and wellness sector.
